Therapeutic Areas: Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Immunology | Infections and Infectious Diseases

Allergy Clinical Trials


A listing of Allergy medical research trials actively recruiting patient volunteers. Click on the closest state and city to find more detailed information on a research study in your area.

Alabama

Birmingham : Research Site

Asthma Clinical Research Study

Foley : Research Site

Asthma Clinical Research Study

Huntsville : Research Site

Asthma Clinical Research Study

Arizona

Flagstaff : Research Site

Asthma Clinical Research Study

Glendale : Research Site

Asthma Clinical Research Study

Phoenix : Research Site

Asthma Clinical Research Study

Tucson : Research Site

Asthma Clinical Research Study

Tucson : Research Site

Asthma Clinical Research Study

Tucson : Research Site

Asthma Clinical Research Study

California

Anaheim : Research Site

Asthma Clinical Research Study

Bakersfield : Research Site

Asthma Clinical Research Study

Garden Grove : Research Site

Asthma Clinical Research Study

Newport Beach : Research Site

Asthma Clinical Research Study

Orange : Research Site

Asthma Clinical Research Study

Palmdale : Research Site New

Asthma Clinical Research Study

Rancho Mirage : Research Site

Asthma Clinical Research Study

Redondo Beach : Research Site

Asthma Clinical Research Study

San Jose : Research Site

Asthma Clinical Research Study

Thousand Oaks : Research Site

Asthma Clinical Research Study

Upland : Research Site

Asthma Clinical Research Study

Wildomar : Elite Clinical Trials, Inc.

Does Your Child Suffer from Allergies or Hives?

Fresno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Riverside : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

San Diego : UC San Diego

A Phase 2 clinical study for patients with Peanut-Allergic Children and Adults

San Jose : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Vista : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Colorado

Centennial : Research Site

Asthma Clinical Research Study

Connecticut

Waterbury : Research Site

Asthma Clinical Research Study

Florida

Aventura : Research Site

Asthma Clinical Research Study

Fort Lauderdale : Research Site

Asthma Clinical Research Study

Hialeah : Research Site

Asthma Clinical Research Study

Jacksonville : Research Site

Asthma Clinical Research Study

Kissimmee : Research Site

Asthma Clinical Research Study

Lynn Haven : Research Site

Asthma Clinical Research Study

Lynn Haven : Research Site

Asthma Clinical Research Study

Miami : Research Site

Asthma Clinical Research Study

Miami : Research Site

Asthma Clinical Research Study

Miami Beach : Research Site

Asthma Clinical Research Study

Orlando : Research Site

Asthma Clinical Research Study

Orlando : Research Site

Asthma Clinical Research Study

Tampa : Research Site

Asthma Clinical Research Study

Tampa : Research Site

Asthma Clinical Research Study

Winter Park : Research Site

Asthma Clinical Research Study

Pensacola : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Georgia

Albany : Research Site

Asthma Clinical Research Study

Gainesville : Research Site New

Asthma Clinical Research Study

Gainesville : Research Site

Asthma Clinical Research Study

Lawrenceville : Research Site

Asthma Clinical Research Study

Lawrenceville : Research Site

Asthma Clinical Research Study

Savannah : Research Site

Asthma Clinical Research Study

Smyrna : Research Site

Asthma Clinical Research Study

Idaho

Eagle : Research Site

Asthma Clinical Research Study

Illinois

Chicago : ChicagoENT

A Double-Blind, Randomised, Placebo-Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects

River Forest : Asthma and Allergy Center of Chicago, SC

If you have a cat allergy and have tried different treatments with little or no relief, there may be another option for you

Shiloh : Research Site

Asthma Clinical Research Study

Indiana

Evansville : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Kansas

Lenexa : Research Site

Asthma Clinical Research Study

Overland Park :

A clinical trial seeking patients for a research study for the treatment of Allergies

Kentucky

Fort Mitchell : Research Site

Asthma Clinical Research Study

Louisville : Research Site New

Asthma Clinical Research Study

Louisville : Research Site New

Asthma Clinical Research Study

Bowling Green : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Maine

Bangor : Research Site

Asthma Clinical Research Study

Maryland

Baltimore : Research Site

Asthma Clinical Research Study

Baltimore :

A clinical trial seeking patients for a research study for the treatment of Allergies

Massachusetts

Boston : Boston Children's Hospital

A Phase 2 clinical study for patients with Peanut-Allergic Children and Adults

Michigan

Ann Arbor : ClinSite, LLC

Diagnosed with Dust Mite Allergies?

Port Huron : Research Site New

Asthma Clinical Research Study

Minnesota

Minneapolis : Clinical Research Institute, MN Updated

765 / 766 DUST MITE ALLERGY RESEARCH STUDY

Minneapolis : Clinical Research Institute, MN

767 / VOLUNTARY ADULT ASTHMA RESEARCH STUDY

Minneapolis : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Missouri

Creve Coeur : The Clinical Research Center, LLC

Do you suffer from Cat Allergies and live with a Cat? If so you may qualify for our cat allergy study.

St. Louis : The Clinical Research Center, LLC

Are you plagued by dust mite allergies causing you to sneeze and itch on a daily basis? Then you may qualify for an clinical trial for dust mite allergies.

St. Louis : Research Site

Asthma Clinical Research Study

Nebraska

Bellevue : Research Site

Asthma Clinical Research Study

Papillion : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Nevada

Las Vegas : Research Site

Asthma Clinical Research Study

New York

Bronx : The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore

Diagnosis of Aspirin Hypersensitivity by Measuring Arachidonic Acid Metabolites after Low Dose Aspirin Challenge

Mineola : Winthrop University Hospital Clinical Trials Center

Study for adults with Hereditary Angioedema (HAE)

Staten Island : Research Site New

Asthma Clinical Research Study

Brooklyn : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mineola : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

New York : Mount Sinai Medical Center

A Phase 2 clinical study for patients with Peanut-Allergic Children and Adults

North Carolina

Durham : Research Site

Asthma Clinical Research Study

Huntersville : Research Site

Asthma Clinical Research Study

Raleigh : North Carolina Clinical Research

Dust Mites and the Allergies they cause are in every room. Sneezing? Itchy Eyes? Stuffy Nose? There's room for you in our research study.

Shelby : Research Site New

Asthma Clinical Research Study

Wilmington : Research Site

Asthma Clinical Research Study

Winston-Salem : Research Site

Asthma Clinical Research Study

Ohio

Cincinnati : Research Site

Asthma Clinical Research Study

Cincinnati : Research Site

Asthma Clinical Research Study

Dayton : Research Site

Asthma Clinical Research Study

Kettering : Research Site

Asthma Clinical Research Study

Cincinnati : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cincinnati : Cincinnati Children's Hospital Medical Center

A Phase 2 clinical study for patients with Peanut-Allergic Children and Adults

Oklahoma

Oklahoma City : Research Site

Asthma Clinical Research Study

Oklahoma City : Research Site

Asthma Clinical Research Study

Oklahoma City : Research Site

Asthma Clinical Research Study

Oklahoma City : Research Site

Asthma Clinical Research Study

Oklahoma City : Research Site

Asthma Clinical Research Study

Tulsa : Research Site

Asthma Clinical Research Study

Oregon

Medford : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pennsylvania

Erie : Research Site

Asthma Clinical Research Study

Feasterville : Research Site

Asthma Clinical Research Study

Pittsburgh : Research Site

Asthma Clinical Research Study

Philadelphia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Philadelphia : The Children's Hospital of Philadelphia

A Phase 2 clinical study for patients with Peanut-Allergic Children and Adults

Rhode Island

Warwick : Research Site

Asthma Clinical Research Study

Lincoln : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

South Carolina

Mt. Pleasant : Research Site

Asthma Clinical Research Study

Rock Hill : Research Site

Asthma Clinical Research Study

Mt. Pleasant : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Summerville : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Tennessee

Knoxville : Research Site

Asthma Clinical Research Study

Texas

Allen : Research Site

Asthma Clinical Research Study

Arlington : Research Site

Asthma Clinical Research Study

Austin : Research Site

Asthma Clinical Research Study

Austin : Research Site

Asthma Clinical Research Study

Boerne : Research Site

Asthma Clinical Research Study

Dallas : Research Site

Asthma Clinical Research Study

Dallas : Research Site

Asthma Clinical Research Study

Dallas : Research Site New

Asthma Clinical Research Study

Dallas : Research Site

Asthma Clinical Research Study

Edinburg : Research Site

Asthma Clinical Research Study

Georgetown : Research Site

Asthma Clinical Research Study

Houston : Research Site

Asthma Clinical Research Study

Houston : Research Site

Asthma Clinical Research Study

McKinney : Research Site

Asthma Clinical Research Study

San Antonio : Research Site

Asthma Clinical Research Study

San Antonio : Research Site

Asthma Clinical Research Study

San Antonio : Research Site

Asthma Clinical Research Study

San Antonio : Research Site

Asthma Clinical Research Study

San Antonio : Lung Diagnostics, LTD

Dust Mite Allergy Study

San Antonio : Women's Diagnostics

Dust Mite Allergy Study

San Antonio : Allergy Diagnostics

Dust Mite Allergy Study

Slendora : Research Site New

Asthma Clinical Research Study

Sugar Land : Research Site

Asthma Clinical Research Study

Dallas : Children's Medical Center Dallas

A Phase 2 clinical study for patients with Peanut-Allergic Children and Adults

Utah

Murray : Research Site

Asthma Clinical Research Study

Salt Lake City : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Virginia

Fairfax : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Wisconsin

Greenfield : Research Site

Asthma Clinical Research Study

Madison : Research Site

Asthma Clinical Research Study

Argentina

Caba : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mendoza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mendoza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rosario : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Santa Fe : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Santa Fe : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Canada

Kanata : Kanata Allergy Services

A clinical trial seeking patients for a research study for the treatment of Seasonal Allergic Rhinitis or Asthma

Kingston : Kingston General Hospital

A clinical trial seeking patients for a research study for the treatment of Seasonal Allergic Rhinitis or Asthma

Mississauga : Cheema Research Inc

A clinical trial seeking patients for a research study for the treatment of Seasonal Allergic Rhinitis or Asthma

Mississauga : Inflamax Research

A Phase 2 clinical study for patients with Seasonal Allergic Rhinitis

Montreal : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ottawa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ottawa : Ottawa Allergy Research Corp

A clinical trial seeking patients for a research study for the treatment of Seasonal Allergic Rhinitis or Asthma

Quebec : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St-Charles-Borromée : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Czech Republic

Breclav : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Tabor : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Teplice : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Trutnov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Denmark

Frederiksberg : Section of Paediatric and International nutrition, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen

Patients are needed to participate in a clinical research study of Probiotic (10^9 CFU/day) and Probiotic (10^8 CFU/day) to evaluate Days Absent From Day Care, Respiratory Tract Infections, Gastrointestinal Infections or Allergy

Finland

Helsinki : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Turku : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

France

Paris : Hotel Dieu Hospital

Patients are needed to participate in a clinical research study evaluating Allergy tests

Germany

Berlin : Hospital Charité

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Bonn : St.-Marien-Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Frankfurt : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Geesthacht : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Grosshansdorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Hamburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Leipzig : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Leipzig : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mainz : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rüdersdorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Hungary

Debrecen : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Israel

Haifa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Jerusalem : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Kfar-Sava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Petach Tikva : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rehovot : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Italy

Firenze : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Milano : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pisa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Reggio Emilia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Verona : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Korea, Republic of

Bucheon-Si : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cheongju : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Suwon : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Poland

Bialystok : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lodz : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Portugal

Coimbra : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lisboa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lisboa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Porto : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Vila Nova de Gaia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Romania

Brasov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucuresti : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cluj-Napoca : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Constanta : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Russian Federation

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ryazan : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Saratov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St-Petersburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Slovakia

Bardejov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bratislava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bratislava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Kosice : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Nitra : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ruzomberok : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Trencin : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Spain

Granada : Biosearch S.A.

A clinical trial to evaluate treatments using Damira/Celia peptide hydrolyzed casein and Picot riz/Celia rice/Sanutri arroz for patients with Cow Milk Protein Sensitivity, Tolerance or Growth Failure

Madrid : Hospital Universitario de La Princesa

A Phase 4 clinical study for patients with IgE-mediated Grass Pollen Induced Rhinitis

Turkey

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mersin : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

United Kingdom

Birmingham : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bradford : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

East Yorkshire : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

London : Evelina Children's Hospital - St Thomas' Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Newcastle upon Tyne : Newcastle general hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Newport : David Hyde Allergy Clinic - St. Mary's hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Southampton : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Southampton : Southampton General Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy